<strong>The VT-BEST program mini-internships are designed to expose trainees to “a day on the job” for a variety of career paths, through hands-on exercises, site visits, and/or case discussions with biomedical professionals. Join the VT-BEST Program and AMPEL BioSolutions for a workshop to explore different careers in biomedical research. AMPEL BioSolutions is a biomedical research consultation firm specializing in translational and personalized medicine including drug and target identification, protocol design and management, biomarker identification, and bioinformatic analysis. The guest speakers will be Dr. Lipsky and Dr. Grammer who have over 20 years of collaborative experience in basic research, clinical research, and medicine as well as extensive experience in risk reduction in pharmaceutical development. Possessing a global understanding of the biomedical field as well as a commitment to precision, AMPEL BioSolutions is an intellectual resource for nonprofit organizations, pharmaceutical and biotech companies, and clinical research organizations in need of rapid and specific solutions to biomedical challenges.</strong>

<hr />
<p class="page-heading"><strong>Space is limited! Participants must register in advance. To register for the mini-internship, please click <a title="here" href="http://info.vtc.vt.edu/best/ampel-biosolutions-mini-internship-sign-up-form-3-16-18//">here</a>.</strong></p>
<strong>March 16th, 2018; 10:00 AM – 1:00 PM, Roanoke, VA</strong>

&nbsp;

<strong><img class=" size-medium wp-image-967 alignnone" src="http://info.vtc.vt.edu/best/wp-content/uploads/2018/02/Amrie_web.jpg" alt="JF1_9034" width="140" height="160" /></strong>Dr. Grammer is a Translational Immunologist specializing in human Autoimmune Diseases. She trained at UVA, where she earned her BS in Chemistry &amp; MS in Pharmacology as well as UTSW Medical Center at Dallas where she received her PhD in Immunology. Before moving to Charlottesville Virginia to establish AMPEL BioSolutions in the UVA Research Park, Dr. Grammer headed up the B Cell Biology Group in the Autoimmunity Branch of NIAMS at the NIH. She specializes in clinical trials, biomarkers, cell-cell interactions &amp; the biochemistry of signaling cascades with expertise in primary lymphocyte biology, flow cytometry, and bioinformatics of gene expression &amp; proteomics. Over the last three years, Amrie has been using her knowledge to reposition drugs for Lupus patients (LRxL-STATTM Lupus Drug Repositioning Initiative) and to identify novel therapeutic targets for lupus using meta-analysis of gene expression.

<strong><img class=" size-medium wp-image-967 alignnone" src="http://info.vtc.vt.edu/best/wp-content/uploads/2018/02/Peter_web.jpg" alt="Headshot_Jarrod" width="140" height="160" /></strong>Dr. Lipsky is a Rheumatologist &amp; Immunologist who immerses himself in basic &amp; clinical research. He received his medical degree from the New York University School of Medicine, completed residency training at the Strong Memorial Hospital in Rochester, New York and his post-doctoral fellowship in NIAID at the NIH. After going to UT Southwestern Medical Center at Dallas, Peter rapidly advanced to become a professor of Internal Medicine and Microbiology as well as the Director of the Harold C Simmons Arthritis Research Center, Co-Director of the Immunology Graduate Program, and Director of the Rheumatic Disease Division of the Department of Internal Medicine. He entered the new millennium as the Director of the Intramural Research Program &amp; the Autoimmunity Branch of NIAMS at the NIH. Dr. Lipsky is the co-founder of AMPEL BioSolutions LLC and directs its clinical operations. He is involved in the Lupus Clinical Investigator Network (LuCINTM) of the LRxL-STATTM Lupus Drug Repositioning Initiative.